EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective study

Junjie Zhao, Runxi Zhuge, Bangchuan Hu, Yesong Wang, Xingxing Wang, Yi Zhang, Lingmin Yuan, Canhu Qiu, Youqin Yan, Xiaojing Zhang, Zhidan Hua, Jing Tang und 8 weitere

Infection · 2025

DOI: 10.1007/s15010-025-02520-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Infection, 2025. Verfasst von Junjie Zhao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China. Hauptthemen laut MEDLINE: Community-Acquired Infections, Bronchoalveolar Lavage Fluid, Immunocompromised Host, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Project of Zhejiang Provincial Department of Health, Quzhou Bureau of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: An increasing number of critically ill patients are immunocompromised. These patients are at high risk of intensive care unit (ICU) admission because of numerous complications. Acute respiratory failure due to severe community-acquired pneumonia (SCAP) is one of the leading causes of admission. Early targeted antibiotic therapy is crucial for improving the prognosis of these patients. Metagenomic next-generation sequencing (mNGS) in bronchoalveolar lavage fluid (BALF) has shown significant value in pathogen detection in recent years. However, there are few studies on summarizing pathogen profiles of SCAP in immunocompromised patients. METHODS: We performed a multicenter retrospective analysis of patients with SCAP in the ICU diagnosed between May 2021 to October 2024. Bronchoalveolar lavage fluid (BALF), blood, and sputum samples were collected and subjected to mNGS and conventional microbiological tests (CMTs). The pathogen profiles detected by the two methods were compared. RESULTS: In our study, compared to CMTs, mNGS increased the detection rates of mixed infections in the immunocompromised group (58.82% vs 17.96%, P < 0.05) and immunocompetent group (44.58% vs 18.72%, P < 0.05), while also reducing the rate of no pathogen detected (4.90% vs 38.73%, P < 0.05; 8.37% vs 32.76%, P < 0.05). In both groups, the proportion of positive clinical impacts (diagnosis) resulting from mNGS results exceeded 90% (96.57% vs 93.84%), and the treatment effectiveness rate in the immunocompromised group was higher than in the immunocompetent group (65.69% vs 56.40%, P < 0.05). Further analysis showed that when mNGS-guided treatment was effective, the 28-day mortality rate significantly improved in both the immunocompromised group (31.34% vs 74.29%, P < 0.05) and the immunocompetent group (42.36% vs 40.68%, P < 0.05) compared to when the treatment was ineffective. CONCLUSION: This study indicates that ICU patients with SCAP, particularly those who are immunocompromised, are more likely to have polymicrobial infections. mNGS in BALF provides rapid and comprehensive pathogen profiling of pulmonary infections, thereby having a positive impact on both the diagnosis, treatment and prognosis of immunocompromised patients with SCAP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired InfectionsBronchoalveolar Lavage FluidImmunocompromised HostHigh-Throughput Nucleotide SequencingMetagenomicsPneumoniaHumansRetrospective StudiesMaleFemaleIntensive Care UnitsMiddle AgedAgedAdultCommunity-Acquired Pneumonia

Stichwörter der Autor:innen

Bronchoalveolar lavage fluidEtiologyMetagenomic next-generation sequencingSevere community-acquired pneumonia

Autor:innen und Institutionen

  • Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China.
  • Shanghai Medical College, Fudan University, 200032, Shanghai, China.
  • Department of Critical Care Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.
  • Department of Critical Care Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
  • Department of Critical Care Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, Zhejiang, China.
  • Department of Critical Care Medicine, Quzhou Kecheng People's Hospital, Quzhou, 324000, Zhejiang, China.

Förderung

  • The Project of Zhejiang Provincial Department of Health
  • Quzhou Bureau of Science and Technology

Zitieren

APA

Zhao, J., Zhuge, R., Hu, B., Wang, Y., Wang, X., Zhang, Y., Yuan, L., Qiu, C., Yan, Y., Zhang, X., Hua, Z., Tang, J., Guo, K., Sun, Y., Wang, K., Qiu, L., Luo, J., Zhang, W., Zhuge, J., & Fang, H. (2025). Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective study. Infection. https://doi.org/10.1007/s15010-025-02520-0

Vancouver

Zhao J, Zhuge R, Hu B, Wang Y, Wang X, Zhang Y, et al. Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective study. Infection. 2025. doi:10.1007/s15010-025-02520-0

BibTeX
@article{Zhao2025,
  author = {Zhao, Junjie and Zhuge, Runxi and Hu, Bangchuan and Wang, Yesong and Wang, Xingxing and Zhang, Yi and Yuan, Lingmin and Qiu, Canhu and Yan, Youqin and Zhang, Xiaojing and Hua, Zhidan and Tang, Jing and Guo, Kai and Sun, Yong and Wang, Kaiyu and Qiu, Liyan and Luo, Jian and Zhang, Weiwen and Zhuge, Jiancheng and Fang, Honglong},
  title = {Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective study},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-025-02520-0}
}
Kostenlos starten →